DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $655,806 | +3.4% | 2,643 | 0.0% | 0.43% | +3.1% |
Q2 2023 | $634,395 | -4.8% | 2,643 | 0.0% | 0.42% | -8.3% |
Q1 2023 | $666,220 | -5.0% | 2,643 | +0.1% | 0.46% | -10.6% |
Q4 2022 | $701,057 | -3.3% | 2,641 | -5.9% | 0.51% | -7.3% |
Q3 2022 | $725,000 | +1.8% | 2,808 | 0.0% | 0.55% | +7.0% |
Q2 2022 | $712,000 | -15.0% | 2,808 | -1.7% | 0.52% | -7.0% |
Q1 2022 | $838,000 | -10.6% | 2,858 | +0.4% | 0.55% | -15.4% |
Q4 2021 | $937,000 | +8.4% | 2,847 | +0.4% | 0.66% | -0.8% |
Q3 2021 | $864,000 | +10.5% | 2,837 | -2.6% | 0.66% | +12.4% |
Q2 2021 | $782,000 | +21.4% | 2,912 | +1.7% | 0.59% | +13.1% |
Q1 2021 | $644,000 | -41.8% | 2,862 | -42.5% | 0.52% | -12.0% |
Q4 2020 | $1,106,000 | +98.6% | 4,976 | +92.3% | 0.59% | -11.8% |
Q3 2020 | $557,000 | +18.3% | 2,588 | -2.8% | 0.67% | +8.3% |
Q2 2020 | $471,000 | +36.5% | 2,662 | +7.0% | 0.62% | +9.2% |
Q1 2020 | $345,000 | -16.9% | 2,489 | -8.0% | 0.57% | +18.7% |
Q4 2019 | $415,000 | – | 2,706 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |